Xenous Holdings, Inc. Files 10-Q for Period Ending December 31, 2023

TL;DR

<b>Xenous Holdings, Inc. (XITO) filed its Q3 2024 10-Q report, detailing financial status and corporate history.</b>

AI Summary

Xenous Holdings, Inc. (XITO) filed a Quarterly Report (10-Q) with the SEC on February 7, 2024. Xenous Holdings, Inc. filed a 10-Q report for the period ending December 31, 2023. The company's fiscal year end is March 31. The filing is for the third quarter of fiscal year 2024. The company was formerly known as M101 CORP. and Concept Holding Corp. The business and mailing address is in Kuala Lumpur, Malaysia.

Why It Matters

For investors and stakeholders tracking Xenous Holdings, Inc., this filing contains several important signals. This 10-Q filing provides investors with the latest financial performance and position of Xenous Holdings, Inc. for the third quarter of fiscal year 2024. Understanding the company's historical name changes and its fiscal year-end is crucial for tracking its financial reporting and understanding its corporate evolution.

Risk Assessment

Risk Level: low — Xenous Holdings, Inc. shows low risk based on this filing. The filing is a standard 10-Q, and no immediate red flags or significant financial distress indicators are present in the provided header information.

Analyst Insight

Review the full 10-Q filing for detailed financial statements, management discussion, and risk factors to assess the company's operational performance and future outlook.

Key Numbers

• 2023-12-31 — Reporting Period End Date (Conformed period of report)
• 2024-02-07 — Filing Date (Filed as of date)
• 03-31 — Fiscal Year End (Company fiscal year end)
• Q3 2024 — Reporting Quarter (Non-accelerated Filer Q3 2024)

Key Players & Entities

• Xenous Holdings, Inc. (company) — Filer name
• M101 CORP. (company) — Former company name
• Concept Holding Corp. (company) — Former company name
• 2023-12-31 (date) — Conformed period of report
• 2024-02-07 (date) — Filed as of date

Forward-Looking Statements

• Xenous Holdings, Inc. will continue to report significant capital deficiencies in future filings. (Xenous Holdings, Inc.) — high confidence, target: 2024-06-30
• The company's stock price will remain highly volatile and speculative due to its financial state. (Xenous Holdings, Inc.) — high confidence, target: 2024-12-31

FAQ

Industry Context

The filing is a standard 10-Q for a publicly traded company, indicating it operates under SEC regulations.

Regulatory Implications

As a public company, Xenous Holdings, Inc. is subject to the reporting requirements of the Securities Exchange Act of 1934.

What Investors Should Do

1. Analyze the detailed financial statements within the 10-Q for revenue, expenses, assets, and liabilities.
2. Review the Management's Discussion and Analysis (MD&A) section for insights into the company's performance and outlook.
3. Examine any disclosed risk factors to understand potential challenges facing the company.

Key Dates

• 2023-12-31: End of Reporting Period — Covers the financial results for the third quarter of fiscal year 2024.
• 2024-02-07: Filing Date — Date the 10-Q report was officially submitted to the SEC.

Year-Over-Year Comparison

This is a 10-Q filing, which is a quarterly report. A comparison to the previous quarter's 10-Q or the prior year's 10-Q would be necessary for a full analysis of changes.

Key Financial Figures

• $0.001 — 2024 was 760,250,000 shares, par value $0.001 per share. XENOUS HOLDINGS, INC. FOR
• $14,923 — te of this filing. We had a net loss of $14,923 and $13,582 for the three months ended
• $13,582 — iling. We had a net loss of $14,923 and $13,582 for the three months ended December 31,
• $45,462 — te of this filing. We had a net loss of $45,462 and $39,209 for the nine months ended D
• $39,209 — iling. We had a net loss of $45,462 and $39,209 for the nine months ended December 31,
• $820,882 — ch 31, 2023, our total liabilities were $820,882 and $775,420, respectively, which were
• $775,420 — our total liabilities were $820,882 and $775,420, respectively, which were current liabi
• $1,131,682 — accumulate. Accumulated deficit was at $1,131,682 as of December 31, 2023, compared to ac
• $1,086,220 — 023, compared to accumulated deficit of $1,086,220 as of March 31, 2023. As of December 3
• $40,168 — flows used in operating activities was $40,168. The net cash used in operating activit
• $5,294 — unts payable and accrued liabilities of $5,294. For the nine months ended December 31
• $48,010 — flows used in operating activities was $48,010. The net cash used in operating activit
• $72 — ed by a decrease in prepaid expenses of $72, and increased by a decrease in account
• $8,873 — unts payable and accrued liabilities of $8,873. Cash Flow from Investing Activities

Filing Documents

• xito_10q.htm (10-Q) — 330KB
• xito_ex311.htm (EX-31.1) — 10KB
• xito_ex312.htm (EX-31.2) — 11KB
• xito_ex321.htm (EX-32.1) — 4KB
• xito_ex322.htm (EX-32.2) — 4KB
• 0001640334-24-000186.txt (&nbsp;) — 1285KB
• xito-20231231.xsd (EX-101.SCH) — 13KB
• xito-20231231_lab.xml (EX-101.LAB) — 82KB
• xito-20231231_cal.xml (EX-101.CAL) — 15KB
• xito-20231231_pre.xml (EX-101.PRE) — 61KB
• xito-20231231_def.xml (EX-101.DEF) — 14KB
• xito_10q_htm.xml (XML) — 89KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1.

Financial Statements

Financial Statements 3 Balance Sheets as of December 31, 2023 and March 31, 2023 (unaudited) 3 4 5 6 Notes to the Unaudited Condensed Financial Statements 7 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 10 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 12 Item 4.

Controls and Procedures

Controls and Procedures 12

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 13 Item 1A.

Risk Factors

Risk Factors 13 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 13 Item 3. Defaults Upon Senior Securities 13 Item 4. Mine Safety Disclosures 13 Item 5. Other Information 13 Item 6. Exhibits 14

SIGNATURES

SIGNATURES 15 2 Table of Contents

Financial Statements

Item 1. Financial Statements XENOUS HOLDINGS, INC. Balance Sheets December 31, 2023 March 31, 2023 (Unaudited) (Audited) ASSET Current Asset Total Current Asset $ - $ - TOTAL ASSET $ - $ - LIABILITIES AND STOCKHOLDERS' DEFICIT Current Liabilities Accounts payable and accrued liabilities $ 19,260 $ 13,966 Due to a related party 801,622 761,454 Total Current Liabilities 820,882 775,420 TOTAL LIABILITIES 820,882 775,420 STOCKHOLDERS' DEFICIT Preferred stock, par value $ 0.001 per share, 10,000,000 shares authorized, no shares issued and outstanding - - Common stock, par value $ 0.001 per share, 10,000,000,000 shares authorized, 760,250,000 shares issued and outstanding 760,250 760,250 Capital deficiency ( 449,450 ) ( 449,450 ) Accumulated deficit ( 1,131,682 ) ( 1,086,220 ) Total Stockholders' Deficit ( 820,882 ) ( 775,420 ) TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ - $ - The accompanying notes are an integral part of these unaudited condensed financial statements. 3 Table of Contents XENOUS HOLDINGS, INC. (unaudited) For the Three Months Ended For the Nine Months Ended December 31, December 31, December 31, December 31, 2023 2022 2023 2022 OPERATING EXPENSES General and administrative $ 442 $ 2 $ 1,422 $ 219 Professional fees 14,481 13,580 44,040 38,990 14,923 13,582 45,462 39,209 NET LOSS $ ( 14,923 ) $ ( 13,582 ) $ ( 45,462 ) $ ( 39,209 ) Basic and Diluted Loss per Common Share $ ( 0.00 ) $ ( 0.00 ) $ ( 0.00 ) $ ( 0.00 ) Basic and Diluted Weighted Average Number of Common Shares 760,250,000 760,250,000 760,250,000 760,250,000 The accompanying notes are an integral part of these unaudited condensed financial statements. 4 Table of Contents XENOUS HOLDINGS, INC. For the nine months ended December 31, 2023 and 2022 (

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS. When used in this Quarterly Report, the words "may," "will," "expect," "anticipate," "continue," "estimate," "project," "intend," and similar expressions are intended to identify forward-looking statements regarding events, conditions, and financial trends that may affect our future plans of operations, business strategy, operating results, and financial position. Persons reviewing this Quarterly Report are cautioned that any forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties and actual results may differ materially from those included within the forward-looking statements as a result of various factors. Such factors are discussed further below and also include general economic factors and conditions that may directly or indirectly impact our financial condition or results of operations. Plan of Operation Our plan of operation for the next 12 months is to: (i) consider guidelines of industries in which we may have an interest; (ii) adopt a business plan regarding engaging in the business of any selected industry; and (iii) to commence such operations through funding and/or the acquisition of a "going concern" engaged in any industry selected. During the next 12 months, our only foreseeable cash requirements will relate to maintaining our good standing or the payment of expenses associated with legal fees, accounting fees and reviewing or investigating any potential business venture, which may be advanced by management or principal stockholders as loans to us. Because we have not determined any business or industry in which our operations will be commenced, and we have not identified any prospective venture as of the date of this Annual Report, it is impossible to predict the amount of any such loan. Any such loan will be on terms no less favorable to us than would be available from a commercial lender in an

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK Pursuant to Item 305(e) of Regulation of S-K (229.305(e)), the Company is not required to provide the information required by this Item as it is a "smaller reporting company," as defined by Rule 229.10(f)(1).

CONTROLS AND PROCEDURES

ITEM 4. CONTROLS AND PROCEDURES Disclosure Controls and Procedures Disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in rules and forms adopted by the Securities and Exchange Commission, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Secretary, to allow timely decisions regarding required disclosures. Under the supervision and with the participation of our management, including our Chief Executive Officer and Secretary, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Quarterly Report. Based upon that evaluation, our Chief Executive Officer and Secretary concluded that, as of the end of the period covered by this Quarterly Report, our disclosure controls and procedures were not effective. Changes in Internal Control Over Financial Reporting During the fiscal quarter covered by this Quarterly Report, there has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. 12 Table of Contents

– OTHER INFORMATION

PART II – OTHER INFORMATION

LEGAL PROCEEDINGS

ITEM 1. LEGAL PROCEEDINGS Management is not aware of any legal proceedings contemplated by any governmental authority or any other party involving us. As of the date of this Quarterly Report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. Management is not aware of any other legal proceedings pending or that have been threatened against us.

RISK FACTORS

ITEM 1A. RISK FACTORS As a "smaller reporting company" as defined by Item 10 of Regulation S-K, the Company is not required to provide this information.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS There were no unregistered sales of our equity securities during the period covered by this quarterly report.

DEFAULTS UPON SENIOR SECURITIES

ITEM 3. DEFAULTS UPON SENIOR SECURITIES None.

MINE SAFETY DISCLOSURES

ITEM 4. MINE SAFETY DISCLOSURES Not applicable.

OTHER INFORMATION

ITEM 5. OTHER INFORMATION None. 13 Table of Contents

EXHIBITS

ITEM 6. EXHIBITS Exhibits: 31.1 Rule 13(a)-14(a)/15(d)-14(a) Certification of Chief Executive Officer 31.2 Rule 13(a)-14(a)/15(d)-14(a) Certification of Chief Financial Officer 32.1 Section 1350 Certification by Chief Executiv

View Full Filing

View this 10-Q filing on SEC EDGAR